Triple
T2190767
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Janssen COVID-19 Vaccine |
E49854
|
entity |
| Predicate | trialSponsor |
P2158
|
FINISHED |
| Object | Janssen Pharmaceuticals |
E248879
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Janssen Pharmaceuticals | Statement: [Janssen COVID-19 Vaccine, trialSponsor, Janssen Pharmaceuticals]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Janssen Pharmaceuticals Context triple: [Janssen COVID-19 Vaccine, trialSponsor, Janssen Pharmaceuticals]
-
A.
Janssen Pharmaceuticals
chosen
Janssen Pharmaceuticals is a global pharmaceutical company, part of Johnson & Johnson, known for developing and marketing a wide range of prescription medicines across areas such as immunology, oncology, neuroscience, and cardiovascular disease.
-
B.
Janssen Biotech
Janssen Biotech is a biopharmaceutical company known for developing and manufacturing innovative biologic therapies, including the blockbuster monoclonal antibody Remicade.
-
C.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
-
D.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
-
E.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: trialSponsor Context triple: [Janssen COVID-19 Vaccine, trialSponsor, Janssen Pharmaceuticals]
-
A.
sponsors
Indicates that one entity provides financial or material support to another, often in exchange for association, promotion, or fulfillment of certain activities or goals.
-
B.
sponsorInHouse
Indicates that one entity formally supports, promotes, or funds another entity within the same organization, institution, or internal setting.
-
C.
sponsorType
Indicates the specific role or category of sponsorship that an entity provides in relation to another entity or event.
-
D.
sponsoringInstitution
chosen
Indicates that an institution provides financial or organizational support to enable or underwrite an activity, project, event, or entity.
-
E.
coSponsor
Indicates that an entity jointly supports, endorses, or backs an initiative, proposal, or activity together with one or more others.
- F. None of above.
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a88aaba3c48190b351cab9b26989ff |
completed | March 4, 2026, 7:40 p.m. |
| NER | Named-entity recognition | batch_69abbf9e99f08190892d34485c8f2f25 |
completed | March 7, 2026, 6:03 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69aea8578f708190be9f952e905eb6be |
completed | March 9, 2026, 11 a.m. |
| PD | Predicate disambiguation | batch_69abbda32d1881909d1fd83a751fb21c |
completed | March 7, 2026, 5:54 a.m. |
Created at: March 4, 2026, 7:46 p.m.